YB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology |  | 2024 | 33 | 35 | ||
| Myeloproliferative neoplasms in young patients: clinical features and specific management |  | 2024 | 119 | 8 | |||
| Low plasma levels of hyaluronic acid might rule out sinusoidal obstruction syndrome after hematopoietic stem cell transplantation | Disease markers | | 2023 | 80 | 78 | ||
| Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs | Blood advances | | 2022 | 61 | 47 | ||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | 2022 | 135 | 108 | ||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | | 2021 | 346 | 0 | ||
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | | 2020 | 337 | 297 | ||
| COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency | European Journal of Haematology | | 2020 | 320 | 154 | ||
| Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts | Biology of Blood and Marrow Transplantation | | 2020 | 334 | 242 | ||
| Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | | 2018 | 542 | 2 | ||
| Validation de l'index de risque lié à la pathologie chez les patients ayant bénéficié d'une allogreffe de cellules souches hématopoïétiques partiellement déplétée en lymphocytes T in vitro | | 2018 | 613 | 6 | |||
| Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome | Bone Marrow Transplantation | | 2018 | 454 | 0 | ||
| FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission | Hematological oncology | | 2017 | 537 | 3 | ||
| Thromboses veineuses splanchniques | Revue médicale suisse | | 2017 | 438 | 182 | ||
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | | 2017 | 557 | 4 | ||
| Pegylated interferon alpha-2a for essential thrombocythaemia during pregnancy, outcome and safety: a case series | Haematologica | | 2016 | 397 | 0 | ||
| Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera? | Future oncology | | 2016 | 1,029 | 3 | ||
| Complete remission of disseminated granulomatous dermatitis related to chronic eosinophilic leukemia following allogeneic stem cell transplantation | Leukemia & lymphoma | | 2016 | 1,210 | 1 | ||
| Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index | Bone marrow transplantation | | 2016 | 648 | 2 | ||
| Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants | Bone marrow transplantation | | 2016 | 674 | 4 | ||
| Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis | British journal of haematology | | 2016 | 496 | 0 | ||
| Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study | Neurology® neuroimmunology & neuroinflammation | | 2015 | 485 | 329 | ||
| Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? | Platelets | | 2015 | 678 | 3 | ||
| Pacritinib: a new agent for the management of myelofibrosis? | Expert opinion on pharmacotherapy | | 2015 | 497 | 2 | ||
| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | | 2014 | 616 | 1 | ||
| Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation | International journal of hematology | | 2014 | 529 | 0 | ||
| Surveillance biologique des héparines et du fondaparinux | Revue médicale suisse | | 2011 | 605 | 4 | ||
| A body-packer with a cocaine bag stuck in the stomach | World journal of radiology | | 2011 | 920 | 524 |
